Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
fungal infection
|
| gptkbp:affects |
gptkb:skin
brain humans lungs sinuses immunocompromised individuals |
| gptkbp:alsoKnownAs |
black fungus
|
| gptkbp:cause |
pulmonary infection
gastrointestinal infection orbital cellulitis disseminated infection cavernous sinus thrombosis cutaneous infection tissue necrosis |
| gptkbp:causedBy |
gptkb:Mucorales_fungi
|
| gptkbp:diagnosedBy |
gptkb:culture
microscopy tissue biopsy |
| gptkbp:fatalIfUntreated |
true
|
| gptkbp:firstDescribed |
1885
|
| https://www.w3.org/2000/01/rdf-schema#label |
mucormycosis
|
| gptkbp:ICD-10_code |
B46
|
| gptkbp:mortalityRate |
high
|
| gptkbp:notableOutbreaks |
gptkb:India_COVID-19_pandemic
|
| gptkbp:prevalence |
rare
|
| gptkbp:prevention |
avoidance of unnecessary steroids
control of blood sugar |
| gptkbp:riskFactor |
gptkb:diabetes_mellitus
leukemia organ transplantation immunosuppression corticosteroid use |
| gptkbp:symptom |
fever
headache vision problems nasal congestion facial swelling black lesions on nasal bridge |
| gptkbp:transmission |
inhalation of spores
contaminated wounds |
| gptkbp:treatment |
gptkb:amphotericin_B
gptkb:isavuconazole posaconazole surgical debridement |
| gptkbp:bfsParent |
gptkb:Rhizopus_oryzae
gptkb:Deferoxamine gptkb:242138-07-4 |
| gptkbp:bfsLayer |
6
|